Quintiles Transnational Holdings Inc. (Q): Kevin K Gordon , EVP and COO of Quintiles Transnational Holdings Inc. sold 24,000 shares on Jun 9, 2016. The Insider selling transaction was reported by the company on Jun 10, 2016 to the Securities and Exchange Commission. The shares were sold at $66.41 per share for a total value of $1,593,840.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 16, 2016, Annie H. Lo (director) purchased 502 shares at $64.80 per share price.On May 12, 2016, Kevin K Gordon (EVP and COO) sold 24,000 shares at $67.21 per share price.Also, On Sep 3, 2015, Charles Edward Williams (Sr VP and Controller) sold 5,000 shares at $72.43 per share price.On Aug 7, 2015, John Connaughton (director 10% owner) sold 2,396,792 shares at $77.37 per share price.
Shares of Quintiles Transnational Holdings Inc (Q) ended Thursday, Jun 9, 2016 session in red amid volatile trading. The shares closed down -0.26 points or -0.39% at $66.54 with 15,69,163 shares getting traded. Post opening the session at $66.44, the shares hit an intraday low of $66.16 and an intraday high of $66.77 and the price vacillated in this range throughout the day. The company has a market cap of $7,963 M and the number of outstanding shares has been calculated to be 11,96,68,196 shares. The 52-week high of Quintiles Transnational Holdings Inc is $80.45 and the 52-week low is $55.011.
Company has been under the radar of several Street Analysts.Quintiles Transnational Holdings Inc is Downgraded by Wells Fargo to Market Perform. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on May 12, 2016.Quintiles Transnational Holdings Inc is Downgraded by Robert W. Baird to Neutral while Lowering the Price Target of the company shares to $ 74 from a previous price target of $76 . Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on May 4, 2016.Quintiles Transnational Holdings Inc is Downgraded by Citigroup to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on May 4, 2016.Quintiles Transnational Holdings Inc is Downgraded by Sun Trust Rbsn Humphrey to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Mar 28, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.